Jazz Pharmaceuticals plc — Director's Dealing 2013

Dec 11, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2013-12-09

Reporting Person: Tobias Jeffrey K (EVP, Research & Dev and CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-12-09	Ordinary Shares	M	1325	$46.83	Acquired	46102	Direct
2013-12-09	Ordinary Shares	S	1325	$117.80	Disposed	44777	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-09	Nonstatutory Stock Option (right to buy)	$46.83	M	1325	Disposed	2022-08-08	Ordinary Shares (1325)	Direct

Footnotes

F1: Includes 372 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 29, 2013.

F2: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3: This nonstatutory stock option is part of an option granted on August 9, 2012 that consisted of the nonstatutory stock option exercisable for 61,460 ordinary shares and an incentive stock option exercisable for 8,540 ordinary shares and has a vesting schedule of one fourth vested on August 9, 2013 and the remainder vesting in 36 equal monthly installments thereafter.